
Kobayashi Pharma Scandal Impacts Over 33,000 Japanese Firms
Kobayashi Pharmaceutical’s red yeast rice products have been linked to health issues, potentially impacting over 33,000 businesses in Japan, including retailers and medical enterprises.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
Kobayashi Pharmaceutical’s red yeast rice products have been linked to health issues, potentially impacting over 33,000 businesses in Japan, including retailers and medical enterprises.
Japan’s Kobayashi Pharmaceutical faces another factory inspection amid a health crisis linked to its red yeast rice supplements, causing multiple deaths and hospitalizations.
Five deaths reported due to red yeast rice supplements from Kobayashi Pharmaceutical, triggering a crisis of confidence and widespread product recalls across Japan.